CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Report for D019964: Mood Disorders NIH

(Synonyms: Mood Disorder, Mood Disorders)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug418 Biological: mRNA-1273: 100 mcg Wiki 0.71
drug419 Biological: mRNA-1273: 50 mcg Wiki 0.71
drug2122 Placebo Wiki 0.04

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D004194 Disease NIH 0.24
D001008 Anxiety Disorders NIH 0.11

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There are 2 clinical trials

Clinical Trials


1 Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth

This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood dysregulation (SMD) display chronic anger, sadness, or irritability, as well as hyperarousal (such as insomnia, distractibility, hyperactivity) and extreme responses to frustration (such as frequent, severe temper tantrums). Researchers will describe the moods and behaviors of children with these symptoms and use specialized testing and brain imaging to learn about the brain changes associated with this disorder.

NCT00025935 Mood Disorder
MeSH:Disease Mood Disorders

Primary Outcomes

Description: This study will examine between-group differences in clinical, behavioral, genetic, neuroanatomical, and neurophysiological variablesin individuals with SMD or DMDD and/or MDD, BD (BD, see protocol 00-M-0198) or those with anxiety (01-M-0192) (Leibenluf

Measure: This study will examine between-group differences in clinical, behavioral, genetic, neuroanatomical, and neurophysiological variables

Time: ongoing

2 Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers

Background: The COVID-19 outbreak has caused many changes to people s normal social patterns. The respiratory illness has been the major focus of public health efforts. But most experts also agree that government and public health mandates to slow the spread of the illness, such as social distancing, have a significant effect on people s mental health. Environmental stressors, such as constraints on activities, social contact, and access to resources, take a toll. Researchers want to learn how stressors related to COVID-19 affect mental health over time. Objective: To learn the relationship between stressors related to COVID-19 and self-rated measures of mental health symptoms and distress among a range of people. Eligibility: English-speaking adults ages 18 and older Design: This study will be conducted online. Participants will give their first and last name and email address. They will indicate if they have ever been in an NIH research study. They will get a username and password. Every 2 weeks for up to 6 months, participants will complete online study surveys. They will get email reminders. Some surveys will be repeated. At the end of the study, they will complete a set of end-of-study surveys. The surveys will ask about the following: Age, sex, race, and other sociodemographic data Mental and medical illness history and treatment Family medical history Mobility, self-care, and life activities Behaviors related to alcohol and substance use disorder Mental illness symptoms Psychological distress Stressors caused by the COVID-19 pandemic. Participants will get links to mental health resources, such as hotlines. They will also get guidance on steps to take to seek care or support. Study website: nimhcovidstudy.ctss.nih.gov

NCT04339790 Healthy Volunteer Mood Disorder Anxiety Disorder Preexisting Medical Condition
MeSH:Disease Anxiety Disorders Mood Disorders

Primary Outcomes

Description: Thoughts and feelings about mental health impact of COVID-19

Measure: NIMH COVID Study survey - adult responses

Time: Biweekly online responses

Secondary Outcomes

Description: Ratings on measures of mental health symptoms and distress

Measure: DSM XC and KS survey

Time: Biweekly online self report


HPO Nodes